Skip to main content
OpenTrials
Terminated

NCT Number: NCT04811235

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial

The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time. Our testing of this novel NIRS sensor in patients with acute SCI represents the first step in translating this technology for human use.

Why the study stopped: Following an SAE, a sensor refinement process was initiated. Although the SAE appears unrelated to the device, the refined sensor did not meet sensitivity/performance required for clinical use. It was deemed most appropriate to terminate the study.
Terminated

Looking for future studies?

Notify Me

Key information

Conditions

Acute Spinal Cord Injury Central Nervous System Diseases Nervous System Diseases Spinal Cord Diseases Spinal Cord Injuries Trauma, Nervous System Wounds and Injuries

Age range

17 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vancouver General Hospital

Vancouver, British Columbia, V5Z1M9, Canada

About this study

This single-center, prospective observational study will enroll 10 patients admitted to Vancouver General Hospital (VGH) for treatment of an acute traumatic spine injury.

Promising preclinical data demonstrates that the oxygenation and hemodynamic measures of our Near Infra-Red Spectroscopy (NIRS) system closely match the invasive intraparenchymal measures obtained within the injured spinal cord. Further, the NIRS sensor is responsive and reflective of systemic hemodynamic changes. This clinical protocol represents the first application of this novel NIRS sensor in human SCI. Following operative decompression of the spinal cord via a posterior approach, the NIRS sensor will be placed over the dura for 7 days to monitor spinal cord oxygenation and tissue hemodynamics. Patients will be followed for 6 months and data collection for safety, feasibly and efficacy of the NIRS System.

The specific aims of this project are to:

  • Establish the safety, feasibility, and efficacy of our NIRS system in monitoring tissue oxygenation and hemodynamics of the injured spinal cord in human participants.
  • Complete the technical refinement of the NIRS system utilizing an iterative process guided by participant recruitment and data accrual during the trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female aged 17 years or older
  • Spinal injury between bony levels C3 and L1 inclusive
  • Motor complete acute traumatic SCI (AIS A or B) or motor incomplete SCI (AIS C) with a total lower extremity motor score of less than 5
  • Blunt (non-penetrating) SCI requiring posterior laminectomy with stabilization/fusion surgery within 72 hours of injury
  • Able to communicate in English and provide informed consent

Exclusion criteria

  • Isolated radiculopathy or cauda equina injury
  • Spinal cord impairment secondary to tumour, infection, epidural bleeding, or ischemia (in
  • Any condition or injury (e.g. Morel-Lavellee lesion) that would interfere with the application or readings of the NIRS sensor
  • Associated traumatic condition that would interfere with the informed consent process or outcome assessments (e.g. traumatic brain injury, pelvic, abdominal, or thoracic injuries)
  • Any other medical condition that, in the investigator's opinion, would render the protocol procedures dangerous
  • Female patients who are pregnant

Treatment and study plan

Near Infra-Red Spectroscopy (NIRS) Sensor

Device

The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time.

Primary outcomes

  1. Feasibility Assessment - Overall

    Time frame: Day 7

    Study specific questionnaire will collected data on the the ease of sensor application, NIRS monitoring and sensor removal is recorded with this form. Series of questions requiring the assessment of the NIRS system using yes/no and 10-point scoring scale

  2. Feasibility Assessment: Sensor Application

    Time frame: Day 1

    Study specific form will be used record data associated with application of the NIRS sensor, such as the laminectomy and instrumentation data, location of the sensor and ease of application (score out of 10).

  3. Feasibility Assessment: Sensor Removal

    Time frame: Day 7

    Study specific form will be used to record the condition of the sensor and participants' experience (score out of 10) at the time of sensor removal

Other outcomes

  1. Safety Assessment - Neurologic Function

    Time frame: 6 Month

    Neurologic function will be assessed using the International Standards for Neurologic Classification of Spinal Cord Injury (ISNCSCI) to determine if the application, 7-day placement, or removal of the NIRS sensor is associated with any deterioration in spinal cord function.

  2. Safety Assessment - Wound Assessment

    Time frame: Day 7

    The externalization of a foreign body may lead to an increased risk of surgical site infection. Any incidence of wound infection will be monitored and document on a wound assessment form.

  3. Safety Assessment - Adverse Events

    Time frame: 6 Months

    The incidence of AEs in the acute SCI patient population is significant. For the purposes of this study, and in keeping with standard of care on the Acute Spine Unit at study site, all AEs will be recorded utilizing the Spine Adverse Event (SAVES) form, a well-established system for prospectively documenting AEs in spine patients

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Collaborators

  • Congressionally Directed Medical Research Programs
  • United States Department of Defense

Registry information

Official study title

"OMNI-SCI" Trial - "Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury" Trial

Important dates

Study start
2022
Primary completion
2022
Study completion
2026
First posted
Mar 23, 2021
Registry last updated
Sep 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.